Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics

Abstract Background The high drug resistance and metabolic reprogramming of clear cell renal cell carcinoma (ccRCC) are considered responsible for poor prognosis. In-depth research at multiple levels is urgently warranted to illustrate the lipid composition, distribution, and metabolic pathways of c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wen Li, Xiaobin Wang, Xianbin Zhang, Peng Gong, Degang Ding, Ning Wang, Zhifeng Wang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/ff711bc81dd846acba3809596fd5516d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ff711bc81dd846acba3809596fd5516d
record_format dspace
spelling oai:doaj.org-article:ff711bc81dd846acba3809596fd5516d2021-11-14T12:39:53ZRevealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics10.1186/s12944-021-01572-z1476-511Xhttps://doaj.org/article/ff711bc81dd846acba3809596fd5516d2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12944-021-01572-zhttps://doaj.org/toc/1476-511XAbstract Background The high drug resistance and metabolic reprogramming of clear cell renal cell carcinoma (ccRCC) are considered responsible for poor prognosis. In-depth research at multiple levels is urgently warranted to illustrate the lipid composition, distribution, and metabolic pathways of clinical ccRCC specimens. Methods In this project, a leading-edge targeted quantitative lipidomic study was conducted using 10 pairs of cancerous and adjacent normal tissues obtained from ccRCC patients. Accurate lipid quantification was performed according to a linear equation calculated using internal standards. Qualitative and quantitative analyses of lipids were performed with multiple reaction monitoring analysis based on ultra-performance liquid chromatography (UPLC) and mass spectrometry (MS). Additionally, a multivariate statistical analysis was performed using data obtained on lipids. Results A total of 28 lipid classes were identified. Among them, the most abundant were triacylglycerol (TG), diacylglycerol (DG), phosphatidylcholine (PC), and phosphatidylethanolamine (PE). Cholesteryl ester (CE) was the lipid exhibiting the most considerable difference between normal samples and tumor samples. Lipid content, chain length, and chain unsaturation of acylcarnitine (CAR), CE, and DG were found to be significantly increased. Based on screening for variable importance in projection scores ≥1, as well as fold change limits between 0.5 and 2, 160 differentially expressed lipids were identified. CE was found to be the most significantly upregulated lipid, while TG was observed to be the most significantly downregulated lipid. Conclusion Based on the absolute quantitative analysis of lipids in ccRCC specimens, it was observed that the content and change trends varied in different lipid classes. Upregulation of CAR, CE, and DG was observed, and analysis of changes in the distribution helped clarify the causes of lipid accumulation in ccRCC and possible carcinogenic molecular mechanisms. The results and methods described herein provide a comprehensive analysis of ccRCC lipid metabolism and lay a theoretical foundation for cancer treatment.Wen LiXiaobin WangXianbin ZhangPeng GongDegang DingNing WangZhifeng WangBMCarticleClear cell renal cell carcinomaLipidsLipidomicsLipid metaboliteLipid biomarkerLipid quantificationNutritional diseases. Deficiency diseasesRC620-627ENLipids in Health and Disease, Vol 20, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Clear cell renal cell carcinoma
Lipids
Lipidomics
Lipid metabolite
Lipid biomarker
Lipid quantification
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle Clear cell renal cell carcinoma
Lipids
Lipidomics
Lipid metabolite
Lipid biomarker
Lipid quantification
Nutritional diseases. Deficiency diseases
RC620-627
Wen Li
Xiaobin Wang
Xianbin Zhang
Peng Gong
Degang Ding
Ning Wang
Zhifeng Wang
Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
description Abstract Background The high drug resistance and metabolic reprogramming of clear cell renal cell carcinoma (ccRCC) are considered responsible for poor prognosis. In-depth research at multiple levels is urgently warranted to illustrate the lipid composition, distribution, and metabolic pathways of clinical ccRCC specimens. Methods In this project, a leading-edge targeted quantitative lipidomic study was conducted using 10 pairs of cancerous and adjacent normal tissues obtained from ccRCC patients. Accurate lipid quantification was performed according to a linear equation calculated using internal standards. Qualitative and quantitative analyses of lipids were performed with multiple reaction monitoring analysis based on ultra-performance liquid chromatography (UPLC) and mass spectrometry (MS). Additionally, a multivariate statistical analysis was performed using data obtained on lipids. Results A total of 28 lipid classes were identified. Among them, the most abundant were triacylglycerol (TG), diacylglycerol (DG), phosphatidylcholine (PC), and phosphatidylethanolamine (PE). Cholesteryl ester (CE) was the lipid exhibiting the most considerable difference between normal samples and tumor samples. Lipid content, chain length, and chain unsaturation of acylcarnitine (CAR), CE, and DG were found to be significantly increased. Based on screening for variable importance in projection scores ≥1, as well as fold change limits between 0.5 and 2, 160 differentially expressed lipids were identified. CE was found to be the most significantly upregulated lipid, while TG was observed to be the most significantly downregulated lipid. Conclusion Based on the absolute quantitative analysis of lipids in ccRCC specimens, it was observed that the content and change trends varied in different lipid classes. Upregulation of CAR, CE, and DG was observed, and analysis of changes in the distribution helped clarify the causes of lipid accumulation in ccRCC and possible carcinogenic molecular mechanisms. The results and methods described herein provide a comprehensive analysis of ccRCC lipid metabolism and lay a theoretical foundation for cancer treatment.
format article
author Wen Li
Xiaobin Wang
Xianbin Zhang
Peng Gong
Degang Ding
Ning Wang
Zhifeng Wang
author_facet Wen Li
Xiaobin Wang
Xianbin Zhang
Peng Gong
Degang Ding
Ning Wang
Zhifeng Wang
author_sort Wen Li
title Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
title_short Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
title_full Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
title_fullStr Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
title_full_unstemmed Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
title_sort revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
publisher BMC
publishDate 2021
url https://doaj.org/article/ff711bc81dd846acba3809596fd5516d
work_keys_str_mv AT wenli revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
AT xiaobinwang revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
AT xianbinzhang revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
AT penggong revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
AT degangding revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
AT ningwang revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
AT zhifengwang revealingpotentiallipidbiomarkersinclearcellrenalcellcarcinomausingtargetedquantitativelipidomics
_version_ 1718429145911787520